Literature DB >> 33601147

Traditional Chinese medicine and lung cancer--From theory to practice.

Zhang Li1, Zhang Feiyue1, Li Gaofeng2.   

Abstract

With the continuous breakthroughs in molecular biology and biochemistry, we have constantly made great progress in the treatment of lung cancer. There is no doubt that standard treatment (such as surgery, radiotherapy, chemotherapy, targeted therapy, and immunotherapy) has greatly improved the prognosis of lung cancer populations. In particular, the immunotherapy has brought more and more good news to countless lung cancer patients. In contrast to these standard treatments, traditional Chinese medicine (TCM) rarely has a profound and comprehensive overview in the field of lung cancer. This article will summarize the latest progress of TCM in lung cancer which is mainly non-small cell lung cancer (NSCLC) from theory to clinical practice, which would carry forward the sophisticated TCM and promote the development of modern medicine.
Copyright © 2021 The Authors. Published by Elsevier Masson SAS.. All rights reserved.

Entities:  

Keywords:  Adjuvant therapy; Immunotherapy; Lung cancer; Traditional Chinese medicine

Mesh:

Substances:

Year:  2021        PMID: 33601147     DOI: 10.1016/j.biopha.2021.111381

Source DB:  PubMed          Journal:  Biomed Pharmacother        ISSN: 0753-3322            Impact factor:   6.529


  16 in total

1.  Exploration of the Effect and Potential Mechanism of Echinacoside Against Endometrial Cancer Based on Network Pharmacology and in vitro Experimental Verification.

Authors:  Wan Shu; Ziwei Wang; Rong Zhao; Rui Shi; Jun Zhang; Wei Zhang; Hongbo Wang
Journal:  Drug Des Devel Ther       Date:  2022-06-16       Impact factor: 4.319

2.  Alpinia katsumadai Hayata induces growth inhibition and autophagy‑related apoptosis by regulating the AMPK and Akt/mTOR/p70S6K signaling pathways in cancer cells.

Authors:  Weixiao An; Yuxi Zhang; Honglin Lai; Yangyang Zhang; Hongmei Zhang; Ge Zhao; Minghua Liu; Yang Li; Xiukun Lin; Shousong Cao
Journal:  Oncol Rep       Date:  2022-06-22       Impact factor: 4.136

3.  Effect Western Medicines Combined With Nao-Xue-Shu in Patients With Hypertensive Intracerebral Hemorrhage: A Network Meta-Analysis.

Authors:  Li Mei; Mu Fengqun; Liu Xiaozhuo; Wang Qing; Fan Mingming; Zuo Zhengyao; Su Dongpo; Han Qian; Chen Tong
Journal:  Front Pharmacol       Date:  2022-06-15       Impact factor: 5.988

4.  Exploring the possible molecular targeting mechanism of Saussurea involucrata in the treatment of COVID-19 based on bioinformatics and network pharmacology.

Authors:  Dongdong Zhang; Zhaoye Wang; Jin Li; Jianbo Zhu
Journal:  Comput Biol Med       Date:  2022-04-25       Impact factor: 6.698

5.  Chinese Herbal Prescription Fu-Zheng-Qu-Xie Prevents Recurrence and Metastasis of Postoperative Early-Stage Lung Adenocarcinoma: A Prospective Cohort Study Followed with Potential Mechanism Exploration.

Authors:  Sufang Zhang; Wanqing Chen; Yuli Wang; Jianchun Wu; Lili Xu; Yongchun Yu; Jianhui Tian; Rongzhong Xu; Zhihong Fang; Lei Jiang; Yingbin Luo; Yan Li
Journal:  Oxid Med Cell Longev       Date:  2021-05-12       Impact factor: 6.543

Review 6.  Practical Implementation of Artificial Intelligence-Based Deep Learning and Cloud Computing on the Application of Traditional Medicine and Western Medicine in the Diagnosis and Treatment of Rheumatoid Arthritis.

Authors:  Shaohui Wang; Ya Hou; Xuanhao Li; Xianli Meng; Yi Zhang; Xiaobo Wang
Journal:  Front Pharmacol       Date:  2021-12-23       Impact factor: 5.810

7.  Curcumenol triggered ferroptosis in lung cancer cells via lncRNA H19/miR-19b-3p/FTH1 axis.

Authors:  Ruonan Zhang; Ting Pan; Yu Xiang; Mingming Zhang; Han Xie; Zimao Liang; Bi Chen; Cong Xu; Jing Wang; Xingxing Huang; Qianru Zhu; Ziming Zhao; Quan Gao; Chengyong Wen; Wencheng Liu; Weirui Ma; Jiao Feng; Xueni Sun; Ting Duan; Elaine Lai-Han Leung; Tian Xie; Qibiao Wu; Xinbing Sui
Journal:  Bioact Mater       Date:  2021-11-19

8.  Polyacetylenes from Codonopsis lanceolata Root Induced Apoptosis of Human Lung Adenocarcinoma Cells and Improved Lung Dysbiosis.

Authors:  Meng-Chuan Wang; Yu-Fang Wu; Wen-Ying Yu; Bing Yu; Hua-Zhong Ying
Journal:  Biomed Res Int       Date:  2022-02-18       Impact factor: 3.411

9.  Efficacy and safety of oral Chinese medicine on cancer-related fatigue for lung cancer patients after chemotherapy: Protocol for systematic review and meta-analysis.

Authors:  Peijin Li; Qian Wang; Lixing Liu; Rui Zhou; Tingting Liu; Yue Wang; Li Feng
Journal:  PLoS One       Date:  2022-06-30       Impact factor: 3.752

10.  Modified Sijunzi Decoction Inhibits Epithelial-Mesenchymal Transition of Non-Small Cell Lung Cancer by Attenuating AKT/GSK3β Pathway in vitro and in vivo.

Authors:  Niu Shao; Yao Xiao; Jiaxin Zhang; Yuying Zhu; Shenglong Wang; Suzhen Bao
Journal:  Front Pharmacol       Date:  2022-01-17       Impact factor: 5.810

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.